The EASL Liver Cancer Summit 2026 has come to a close. We want to express our heartfelt gratitude to our delegates, faculty, organisers, and sponsors for your active engagement and enthusiasm throughout this extraordinary event!

The EASL Liver Cancer Summit counted 598 delegates from 52 countries, 42 faculty members, 152 posters and 168 abstracts accepted.

Your participation has been crucial in pushing forward our collective knowledge of liver cancer. CME credits will be awarded to all attendees.

Please note that all summit materials will be accessible on demand to registered delegates via the platform and then EASL Campus. This allows you to review and explore the wealth of information and insights presented during the summit at your convenience.